Cryptococcal cellulitis in an immunocompetent host.
Sanchez-Albisua
B
B
Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain.
Rodriguez-Peralto
J L
JL
Romero
G
G
Alonso
J
J
Vanaclocha
F
F
Iglesias
L
L
D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002481:Cellulitis / Q000188:drug therapy / Q000382:microbiology*; D003453:Cryptococcosis / Q000188:drug therapy / Q000473:pathology*; D003881:Dermatomycoses / Q000188:drug therapy / Q000473:pathology*; D005260:Female; D015725:Fluconazole / Q000008:administration & dosage / Q000627:therapeutic use; D005437:Flucytosine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007121:Immunocompetence; D017964:Itraconazole / Q000008:administration & dosage / Q000627:therapeutic use; D007868:Leg Dermatoses / Q000188:drug therapy / Q000382:microbiology*
D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B; D015725:Fluconazole; D005437:Flucytosine